MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.66
-0.19 (-1.13%)
At close: Apr 28, 2026, 4:00 PM EDT
16.76
+0.10 (0.59%)
After-hours: Apr 28, 2026, 7:33 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $1.19 billion as of April 28, 2026. Its market cap has decreased by -44.41% in one year.
Market Cap
1.19B
Enterprise Value
878.16M
1-Year Change
-44.41%
Ranking
Category
Stock Price
$16.66
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.19B, an increase of 33,111.79%. That is a compound annual growth rate of 298.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.21B | 28.48% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 1.31B |
| Savara | 1.30B |
| AbCellera Biologics | 1.26B |
| GH Research | 1.26B |
| Jade Biosciences | 1.23B |
| DBV Technologies | 1.18B |
| Aktis Oncology | 1.18B |
| Pharming Group | 1.17B |